VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
about
Nanomedicine in the application of uveal melanomaVector platforms for gene therapy of inherited retinopathies.Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical applicationA Solution to the Common Problem of the Synthesis and Applications of Hexachlorofluorescein Labeled Oligonucleotides.Ophthalmic light sensitive nanocarrier systems.Mechanisms of Light-induced Liposome Permeabilization.
P2860
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@ast
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@en
type
label
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@ast
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@en
prefLabel
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@ast
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@en
P2093
P1433
P1476
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
@en
P2093
David BenEzra
Fatemeh Valamanesh
Francine Behar-Cohen
Frédéric Mascarelli
Michèle Savoldelli
Nadia Normand
Yves Courtois
P304
P577
2005-03-04T00:00:00Z